SOUTH SAN FRANCISCO, Calif. — September 2, 2025 — Leads & Copy — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”) announced that Timothy Lu, M.D., Ph.D., Co-Founder and CEO, will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York, NY, on Monday, September 8, 2025, at 2:00 PM ET.
Management will also be available for in-person one-on-one meetings with qualified investors registered for the conference. A live video webcast will be available on the company website, with a replay archived for 90 days.
Senti Bio develops next-generation cell and gene therapies using its proprietary Gene Circuit platform, engineering Gene Circuits into new medicines with enhanced precision and control. The company’s pipeline is comprised of cell therapies engineered with Gene Circuits to target liquid and solid tumor indications.
For more information, visit www.sentibio.com or follow Senti Bio on X (@SentiBio) and LinkedIn (Senti Biosciences).
Investor Contact:
Jenene Thomas
JTC Team, LLC
(908) 824-0775
SNTI@jtcir.com
Source: Senti Biosciences, Inc.
Source: Senti Biosciences, Inc.
